RE:RE:RE:RE:Revenue Deal, New Patent Looks Interesting I don't need this to blow up today, it just needs to break the longterm downtrend, which it's been tapping up against for the last several weeks.
This is a revenue deal. The more numbers on a future quarterly there are to assess the better. They can tell everyone they're different than Valens/Medipharms etc but the only thing that will prove it is margins on a quarterly.
hopefull wrote:
let's see how the market responds this morning. It will see this as a blip or a swing change. I'm guessing a blip. Until we get a deal that can actually be named NL will stay in the basement